MCR-1 and OXA-48 in vivo acquisition in KPC-producing Escherichia coli after colistin treatment

The spread of mcr-1-encoding plasmids into carbapenem-resistant Enterobacteriaceae raises concerns about the emergence of untreatable bacteria. We report the acquisition of mcr-1 in a carbapenem-resistant Escherichia coli strain after a 3-week course of colistin in a patient repatriated to France from Portugal. Whole-genome sequencing revealed that the Klebsiella pneumoniae carbapenemase-producing E. coli strain acquired two plasmids, an IncL OXA-48-encoding plasmid and an IncX4 mcr-1-encoding plasmid. This is the first report of mcr-1 in carbapenemase-encoding bacteria in France.

Author(s): Beyrouthy R, Robin F, Lessene A, Lacombat I, Dortet L, Naas T, Pontiès V, Bonnet R

Publishing year: 2017

Pages: pii: e02540-16

In relation to

Our latest news

news

Call for Applications for the Renewal of the Editorial Board of the Weekly...

news

Launch of the “Heating, Health, Buildings, and Urban Planning” Network:...

news

2026 “Sexual Behavior” Survey (ERAS) for men who have sex with men